BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Sinclair Research
Transition Therapeutics is defunct.

Fate: Bought by Opko, $60M stock, July 2016


------------------
If you believe any of this information is incorrect, please let us know.